Mimedx (MDXG) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 32.23% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | 25.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.54% |
| Mar 31, 2026 | 37.68% |
| Dec 31, 2025 | 36.06% |
| Sep 30, 2025 | 24.73% |
| Jun 30, 2025 | 17.92% |
| Mar 31, 2025 | 12.04% |
| Dec 31, 2024 | 6.24% |
| Sep 30, 2024 | -0.67% |
| Jun 30, 2024 | -6.70% |
| Mar 31, 2024 | -16.98% |
| Dec 31, 2023 | -5.06% |
| Jun 30, 2023 | 12.51% |
| Mar 31, 2023 | 4.58% |
| Dec 31, 2022 | -1.53% |
| Sep 30, 2022 | -8.03% |
| Jun 30, 2022 | -9.23% |
| Mar 31, 2022 | 38.64% |
| Dec 31, 2021 | 24.51% |
| Dec 31, 2020 | 51.64% |
| Sep 30, 2020 | 44.24% |